Cavitation Technologies (CVAT) Stock Price, News & Analysis

Company Overview

Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in the processing of various industrial and consumer-oriented fluids in the United States. It provides Nano Reactor and Nano Neutralization Systems for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. The company also develops technology-based systems for various markets, including renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement, as well as small home appliances. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.

Key Stats

• Today's Range: $0.0095 to $0.0105
• 50-Day Range: $0.0060 to $0.0126
• 52-Week Range: $0.0011 to $0.0199
• Volume: 579,565 shs
• Average Volume: 263,824 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cavitation Technologies Stock Analysis - MarketRank™

Cavitation Technologies scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cavitation Technologies.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cavitation Technologies is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cavitation Technologies is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cavitation Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cavitation Technologies does not currently pay a dividend.

Dividend Growth

Cavitation Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cavitation Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Cavitation Technologies this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cavitation Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

28.11% of the stock of Cavitation Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 8.53% of the stock of Cavitation Technologies is held by institutions.

CVAT Stock Analysis - Frequently Asked Questions

How have CVAT shares performed this year?

Cavitation Technologies' stock was trading at $0.0163 at the beginning of 2024. Since then, CVAT stock has decreased by 38.0% and is now trading at $0.0101.
View the best growth stocks for 2024 here.

How do I buy shares of Cavitation Technologies?

Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Cavitation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cavitation Technologies investors own include Adamis Pharmaceuticals (ADMP), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Altimmune (ALT) and Digital Ally (DGLY).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Specialty Industrial Machinery
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:CVAT
• CUSIP: N/A
• CIK: 1376793
• Web: www.ctinanotech.com
• Phone: (818) 718-0905
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A